{
    "organizations": [],
    "uuid": "369fcd09c0b97510bcf4b1863d298f408ff1f08a",
    "author": "",
    "url": "https://www.reuters.com/article/brief-corsair-pharma-and-united-therapeu/brief-corsair-pharma-and-united-therapeutics-enter-into-strategic-collaboration-to-advance-novel-treprostinil-prodrugs-idUSFWN1OY02B",
    "ord_in_thread": 0,
    "title": "BRIEF-Corsair Pharma And United Therapeutics Enter Into Strategic Collaboration To Advance Novel Treprostinil Prodrugs",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 12 AM / Updated 3 minutes ago BRIEF-Corsair Pharma And United Therapeutics Enter Into Strategic Collaboration To Advance Novel Treprostinil Prodrugs Reuters Staff \nJan 3 (Reuters) - United Therapeutics Corp: \n* CORSAIR PHARMA AND UNITED THERAPEUTICS ENTER INTO STRATEGIC COLLABORATION TO ADVANCE NOVEL TREPROSTINIL PRODRUGS \n* UNITED THERAPEUTICS SAYS GRANTED EXCLUSIVE LICENSE TO CORSAIR‘S INTELLECTUAL PROPERTY FOR DEVELOPMENT OF TREPROSTINIL PRODRUG FORMULATIONS \n* UNITED THERAPEUTICS CORP - MADE MINORITY EQUITY INVESTMENT IN CORSAIR THAT INCLUDES AN OPTION TO ACQUIRE REMAINING OUTSTANDING SHARES OF CORSAIR \n* UNITED THERAPEUTICS SAYS UNDER TERMS OF LICENSE AGREEMENT, CORSAIR RECEIVED UPFRONT CONSIDERATION \n* UNITED THERAPEUTICS- CORSAIR IS ENTITLED TO ROYALTY PAYMENTS ON COMMERCIALIZATION OF TREPROSTINIL PRODRUG PRODUCTS BY CO COVERED BY CORSAIR‘S PATENTS Source text for Eikon: Further company coverage:",
    "published": "2018-01-03T13:11:00.000+02:00",
    "crawled": "2018-01-03T13:25:30.068+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "pharma",
        "united",
        "therapeutic",
        "enter",
        "strategic",
        "collaboration",
        "advance",
        "novel",
        "treprostinil",
        "prodrugs",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "united",
        "therapeutic",
        "corp",
        "corsair",
        "pharma",
        "united",
        "therapeutic",
        "enter",
        "strategic",
        "collaboration",
        "advance",
        "novel",
        "treprostinil",
        "prodrugs",
        "united",
        "therapeutic",
        "say",
        "granted",
        "exclusive",
        "license",
        "corsair",
        "intellectual",
        "property",
        "development",
        "treprostinil",
        "prodrug",
        "formulation",
        "united",
        "therapeutic",
        "corp",
        "made",
        "minority",
        "equity",
        "investment",
        "corsair",
        "includes",
        "option",
        "acquire",
        "remaining",
        "outstanding",
        "share",
        "corsair",
        "united",
        "therapeutic",
        "say",
        "term",
        "license",
        "agreement",
        "corsair",
        "received",
        "upfront",
        "consideration",
        "united",
        "corsair",
        "entitled",
        "royalty",
        "payment",
        "commercialization",
        "treprostinil",
        "prodrug",
        "product",
        "co",
        "covered",
        "corsair",
        "patent",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}